Charles Schwab Investment Management Inc Jazz Pharmaceuticals PLC Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 615,517 shares of JAZZ stock, worth $87.4 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
615,517
Previous 531,710
15.76%
Holding current value
$87.4 Million
Previous $59.3 Million
27.9%
% of portfolio
0.01%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding JAZZ
# of Institutions
543Shares Held
59MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$873 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$858 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$360 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$315 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$289 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.91B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...